Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Castle Biosciences to Present at the 9th Annual SVB Leerink Global Healthcare Conference


Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced that Derek Maetzold, president and chief executive officer, is scheduled to present a company overview at the 9th Annual SVB Leerink Global Healthcare Conference in New York City on Wednesday, February 26, 2020, at 1:00 p.m. Eastern time.

A live audio webcast of the company's presentation will be available by visiting Castle Biosciences' website at https://ir.castlebiosciences.com/news-events/events-presentations. A replay of the webcast will be available for two weeks following the conclusion of the live broadcast.

About Castle Biosciences

Castle Biosciences (Nasdaq: CSTL) is a commercial-stage dermatologic cancer company focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The Company currently offers tests for patients with cutaneous melanoma (DecisionDx®-Melanoma, DecisionDx®-CMSeq; www.SkinMelanoma.com) and uveal melanoma (DecisionDx®-UM, DecisionDx®-PRAME and DecisionDx®-UMSeq; www.MyUvealMelanoma.com), with products in development for other underserved cancers, the two most advanced of which are focused on patients with cutaneous squamous cell carcinoma, and patients who have a difficult-to-diagnose pigmented lesion. Castle Biosciences is based in Friendswood, Texas (Houston), and has laboratory operations in Phoenix, Arizona. For more information, visit www.CastleBiosciences.com.

DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.


These press releases may also interest you

at 09:05
Community Care Cooperative (C3), the Accountable Care Organization (ACO) that advances community-based care for MassHealth members through its network of 19 health centers throughout the state, today announced the launch of a $5 million campaign to...

at 09:05
NS1, the leader in modern application networking, today announced its compelling lineup of speakers for INS1GHTS2020, a free, interactive digital gathering of industry leaders in NetOps, DevOps, and application delivery. From 6:30 a.m. to 7 p.m. EDT...

at 09:05
Genesis, an industry pioneer and leader in digital currency trading and lending, today announced it has launched a derivatives trading desk. The new offering, which follows last week's announcement that Genesis is launching a prime brokerage service...

at 09:05
Guided Therapeutics, Inc. (Pink Sheets: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced that it had completed software changes and documentation required by the Chinese FDA for...

at 09:05
Kronos: What: Joyce Maroney, executive director of The Workforce Institute at Kronos Incorporated, welcomes Andrew Barnes, founder of New Zealand estate planning company Perpetual Guardian, and Charlotte Lockhart, CEO of 4 Day Week Global....

at 09:05
Aptum, a global hybrid cloud and managed services provider, today launched its Managed DevOps Service in partnership with CloudOps, a cloud consulting and professional services company specializing in DevOps. The Managed DevOps Service offers a...



News published on 12 february 2020 at 07:05 and distributed by: